首页> 外文期刊>Chinese Jouranl of Integrative Medicine >Study on Effect of Compound Sal via Pellet in Preventing Atrial Fibrillation with Left Atrial Thrombosis
【24h】

Study on Effect of Compound Sal via Pellet in Preventing Atrial Fibrillation with Left Atrial Thrombosis

机译:复方丹参颗粒预防房颤并发左房血栓形成的研究

获取原文
获取原文并翻译 | 示例
       

摘要

Atrial fibrillation (AF) is a kind of common arrhythmia, which, besides affecting cardiac function, has another serious outcome, that is, it is easy to form atrial thrombosis and induce thrombus/embolus, especially cerebral embolus. The incidence of left atrial thrombosis (LAT) could reach 25%-30%, the incidence of embolic complication per year could reach 2.98%-6.30%, even 20% or more<2'3). To prevent thrombosis so as to lower the incidence of cerebral stroke and other embolic complications has been so far the focal point of AF treatment. The present study is to observe the effect of compound Salvia pellet (CSP) in treating AF patients with anti-coagulatory treatment indication on concentration change of plasma thromboxane B_2 (TXB_2), 6-keto-postglandin F_(1α) (6-keto-PGF_(1α)) and LAT, embolus incidence, to explore the efficacy and feasibility of Salvia miltiorrhiza in preventing LAT of AF patients.
机译:房颤(AF)是一种常见的心律失常,除影响心脏功能外,还有另一种严重的预后,即容易形成心房血栓形成并诱发血栓/栓塞,尤其是脑栓塞。左心房血栓形成(LAT)的发生率可达到25%-30%,每年栓塞并发症的发生率可达到2.98%-6.30%,甚至20%以上<2'3)。迄今为止,预防血栓形成以降低脑卒中和其他栓塞并发症的发生率一直是AF治疗的重点。本研究旨在观察复方丹参颗粒(CSP)在抗凝治疗适应症AF患者血浆血栓烷B_2(TXB_2),6-酮-postglandin F_(1α)(6-酮- PGF_(1α))和LAT(栓子的发生率),以探讨丹参预防AF患者的LAT的有效性和可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号